Panel to approve new drugs: HC
Ten years after contaminated IV fluids resulted in adverse reactions in several patients in Safdarjung hospital, the Delhi High Court ruled that no new drug would be permitted in the market unless
Related Content
- Green panel okays Aurobindo Pharma's Telangana unit expansion
- Bangladesh State of Environment Report: The Monthly Overview, April 2014
- Panel rejects clinical trial plea by some drug makers
- India State of the Environment Report : The Monthly Overview, September 2013
- Panel recommends sweeping changes in clinical trials process
- Lens on Ethics Panels for Clinical Tests